Women, on average, lose more weight than men on equivalent doses, possibly due to interactions between GLP-1 signaling and estrogen
In einer Studie zu unerwnschten gastrointestinalen Wirkungen bei adipsen Nichtdiabetikern, die GLP-1-Agonisten (Semaglutid oder Liraglutid) zur Gewichtsabnahme einsetzten, wurde ein signifikant erhhtes Risiko fr Pankreatitis (Entzndung der Bauchspeicheldrse) und Ileus (Dnndarmverschluss) und festgestellt
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, has transformed treatment for type 2 diabetes and obesity
The Rapid Service Fee was funded by the authors
In terms of secondary outcomes, the ALC group was also more likely to have had an improvement in cancer-related fatigue (31% vs